Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Clinical Trial

Recap of Wednesday's Biotech Catalysts - End of The Day Summary

IDEAYA Biosciences (NASDAQ:IDYA) has entered into a clinical trial collaboration and supply agreement with Amgen Inc. to evaluate the efficacy and safety of IDE397 with Amgen's AMG 193 in a Phase 1 clinical trial. IDEAYA shares traded in a range of $14.59 to $15.82 on a day volume of 130.58…

Benzinga

Family plea to get ill Co Tyrone man home after receiving cancer treatment in US

Cormac McLaughlin from Castlederg had travelled to Texas where he was accepted on a to a clinical trial to help save his life

Belfast Live

What is Paxlovid? Everything you need to know about Joe Biden’s antiviral Covid drug treatment

Late-stage clinical trial found nearly 90 per cent effectiveness from antiviral pill

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Recap Of Tuesday's Biotech Catalysts - End of The Day Summary

European Commission (EC) has approved AbbVie’s (NYSE:ABBV) lead asset RINVOQ (upadacitinib 45 mg [induction dose] and 15 mg and 30 mg [maintenance doses]) for the treatment of adult patients with moderately to severely active ulcerative colitis. AbbVie shares traded in a range of $150.33 to $153.56 on a day volume…

Benzinga

NSW pitched as clinical trial hub in Seoul

With another potential COVID-19 wave on the way in Australia, NSW Premier Dominic Perrottet is pitching his state as a clinical trial hub to Korean scientists.

AAP

InMed Provides An Update On Phase 2 Clinical Trial Investigating Cannabinol Cream For Epidermolysis Bullosa

InMed Pharmaceuticals Inc. (NASDAQ: INM) provided an update on its phase 2 clinical trial using investigational drug INM-755 cannabinol (“CBN”) cream for the treatment

Benzinga

Meaghan thought psychedelic therapy could help her PTSD. Instead it was the start of a nightmare

When Meaghan did psychedelic therapy she was gagged and pinned down by her therapists. With psychedelics touted as a miracle cure, she wants her story known.

ABC News

Read news from The Economist, FT, and more,
with one subscription

Recap Of Friday's Biotech Catalysts - End Of The Day Summary

Bristol Myers Squibb (NYSE:BMY) received European Medicines Agency (EMA) Positive CHMP Opinion recommending approval for Opdualag (nivolumab and relatlimab) for treatment of patients with Unresectable or Metastatic Melanoma based on results from the Phase 2/3 RELATIVITY-047 trial. Bristol Myers shares traded in a range of $72.48 to $73.61 on a…

Benzinga

Hallucinations are very much a part of my life – David Jensen

The DJ, nicknamed Kid, has been living with Parkinson’s disease for more than a decade.

The Independent UK

Field Trip's Phase I Clinical Study Of Psilocybin Analog FT-104 Begins Dosing In Australia

Developer and provider of psychedelic therapies Field Trip Health Ltd. has announced the first successful dosing of a Phase 1 clinical trial on it's proprietary psychedelic molecule.

Benzinga

What is Paxlovid? Everything you need to know about the antiviral Covid drug being taken by Joe Biden

Late-stage clinical trial found nearly 90 per cent effectiveness from antiviral pill

The Independent UK

Incannex Approved To Commence Phase 1 Clinical Trial Of CBD Based Anti-Inflammatory Drug

Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) has received approval from the Bellberry Human Research Ethics Committee ('HREC') for a phase 1 clinical trial investigating its proprietary multi-use, anti-inflammatory drug IHL-675A

Benzinga

Skye Bioscience Selects NextPharma As Phase 2 Contract Drug Manufacturer

Skye Bioscience, Inc. (OTCQB: SKYE) , a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative to treat glaucoma, has selected NextPharma as its contract manufacturing organization (“CMO”) for its Phase 2 clinical trial mat

Benzinga

Phase 3 Trial On Ketamine Therapy Gets Almost $2M From UK State Funding

Biotech psychedelics company Awakn Life Sciences Corp. (OTCQB: AWKNF) has been granted funding for 66% of the costs from its phase 3 clinical trial on

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Recap of Wednesday's Biotech Catalysts - End of The Day Summary

Benzinga

Recap of Tuesday's Biotech Catalysts - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in adults with narcolepsy.

Daily Record

Scots nurse with terminal cancer needs £50,000 for treatment that could add years to life

Sarah McCrimmon, from Potterhill in Paisley, has been given hope of recovery from a rare form of kidney cancer that has blighted her life since she was 13.

Benzinga

Alterity Commences Mid-Stage Neurodegenerative Disorder Study

Alterity Therapeutics (NASDAQ: ATHE) doses first subject in its Phase 2 clinical trial of lead candidate ATH434 in Multiple System Atrophy (MSA), a rare and highly debilitating Parkinsonian disorder.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Ayala Reveals Positive Results From Phase 2/3 Desmoid Tumors Study

Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) announced positive interim results from Part A of the ongoing RINGSIDE Pivotal Phase 2/3 clinical trial evaluating AL102 in desmoid tumors.

Benzinga

Dyne's Shares Gain After FDA Removed Clinical Hold On Muscular Disease Study

Dyne Therapeutics (NASDAQ: DYN) announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold and cleared its Investigational New Drug (IND) application to initiate a clinical trial of its drug DYNE-25.

Daily Record

Clinical trial into potential cancer vaccine 'shows early promising results'

The vaccine, which has been codenamed TG4050, uses similar technology to that of the coronavirus jabs.

Edinburgh Live

Edinburgh mum's persistent cough turned out to be advanced breast cancer

Lesley Stephen was diagnosed with incurable secondary breast cancer in 2014 and just as she thought her time was coming to an end, she found a 'miracle' in a patient trial.

The Times of India

Indian-origin woman gets cancer-free following drug trial in UK

Miracles happen when science progresses! Jasmin David, a 51-year-old Indian-origin woman from Manchester, was given just months to live a few years ago due to breast cancer. Now, doctors have declared that she is showing no evidence of cancer, after undergoing a clinical trial at a UK hospital.

The Independent UK

Woman given one year to live is now cancer-free after experimental treatment

Jasmin David took part in a clinical trial with experimental medicines

Belfast Live

Meet the NI woman aiming to improve lives of cancer patients with innovative technology

The technology is preparing for its first human clinical trial

1 … 16 17 18 19

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.